This document provides definitions and information about communicable diseases (CD) and their transmission. It begins with learning objectives and then defines key terms related to CD and transmission. It discusses how CD can be classified based on causative organisms, clinical presentation, or body system affected. The document also covers reservoirs of infection, the chain of disease transmission including the six steps, and effects of agents on hosts. It provides examples of reservoirs including humans, animals, and the environment.
Bacteria of the genus Salmonella are highly adapted for growth in both humans and animals and cause a wide spectrum of disease.
The growth of S. Typhi and S. Paratyphi is restricted to human hosts, in whom these organisms cause enteric (typhoid) fever.
The remaining serotypes (non-typhoidal Salmonella or NTS) can colonize the gastrointestinal tracts of a broad range of animals, including mammals, reptiles, birds and insects.
Pharmacology of Penicllins (Beta lactam antibiotics), description of their mechanism of action, mechanism of resistance, classification, indications and adverse effects
The current slide include the pharmacology og cephalosporins.
Contents
Introduction to Cephalosporins
Classification of Cephalosporins
Cefazolin
Cephalexin
Cefuroxime
Cefuroxime axetil
Cefotaxime
Cefixime
Cefpodoxime proxetil
Cefepime
Adverse effects of Cephalosporins
Uses of Cephalosporins
Bacteria of the genus Salmonella are highly adapted for growth in both humans and animals and cause a wide spectrum of disease.
The growth of S. Typhi and S. Paratyphi is restricted to human hosts, in whom these organisms cause enteric (typhoid) fever.
The remaining serotypes (non-typhoidal Salmonella or NTS) can colonize the gastrointestinal tracts of a broad range of animals, including mammals, reptiles, birds and insects.
Pharmacology of Penicllins (Beta lactam antibiotics), description of their mechanism of action, mechanism of resistance, classification, indications and adverse effects
The current slide include the pharmacology og cephalosporins.
Contents
Introduction to Cephalosporins
Classification of Cephalosporins
Cefazolin
Cephalexin
Cefuroxime
Cefuroxime axetil
Cefotaxime
Cefixime
Cefpodoxime proxetil
Cefepime
Adverse effects of Cephalosporins
Uses of Cephalosporins
This powerpoint, deals with HIV pathophysiology, signs and symptoms, mode of transmission and diagnostic parameters.
Purely based on clinical pharmacist perspective.
THERE ARE VARIOUS FACTORS AFFECTING DRUG ACTION.
THEY MAY BE SUBJECT OR DRUG RELATED AND ARE AS FOLLOWS :
• BODY SIZE
• BODY WEIGHT OR BODY SURFACE AREA
• AGE
• SEX
• RACE OR SPECIES
• DOSE
• PHYSIOLOGICAL STATE
• PATHOLOGICAL STATE
• PSYCHOLOGICAL STATE
• GENETIC FACTOR
The main focus of this presentation is to discuss all the drugs used nowadays in clinical practice to treat/ manage bronchial asthma. Along with the mechanism of action, use and adverse effects of anti-asthma drugs, we have given a highlight of the pathophysiology of asthma and how the drugs individually act at individual set point(s) to bring the clinical outcome.
Overview of these drug. About Pain & Fever and Mechanisms of Action with Binding Receptor. Also have Pain scale, Choice of Drug and Their Side Effect, Adverse Effect. About Misuse of These Drug & Management
This powerpoint, deals with HIV pathophysiology, signs and symptoms, mode of transmission and diagnostic parameters.
Purely based on clinical pharmacist perspective.
THERE ARE VARIOUS FACTORS AFFECTING DRUG ACTION.
THEY MAY BE SUBJECT OR DRUG RELATED AND ARE AS FOLLOWS :
• BODY SIZE
• BODY WEIGHT OR BODY SURFACE AREA
• AGE
• SEX
• RACE OR SPECIES
• DOSE
• PHYSIOLOGICAL STATE
• PATHOLOGICAL STATE
• PSYCHOLOGICAL STATE
• GENETIC FACTOR
The main focus of this presentation is to discuss all the drugs used nowadays in clinical practice to treat/ manage bronchial asthma. Along with the mechanism of action, use and adverse effects of anti-asthma drugs, we have given a highlight of the pathophysiology of asthma and how the drugs individually act at individual set point(s) to bring the clinical outcome.
Overview of these drug. About Pain & Fever and Mechanisms of Action with Binding Receptor. Also have Pain scale, Choice of Drug and Their Side Effect, Adverse Effect. About Misuse of These Drug & Management
Why Chatbots Will Transform Mobile IntranetsTangowork
Demos of 8 different chatbots. 6 core use cases for chatbots. 9 reasons why chatbots will power the next generation of mobile intranets. As presented at IntraTeam Event 2017 in Copenhagen.
infectious-diseases -lec 1.pptGangrene is a clinical condition of ischemic an...RabeaDia
Gangrene is a clinical condition of ischemic and necrotic tissue, often circumferential around a digit or extremity. It is identified by discolored or black tissue and associated sloughing of natural tissue planes. The three main types of gangrene are wet gangrene, dry gangrene, and gas gangrene.Aug 7, 2023
this power point slide consists the important points regarding to infectious diseases control, helps for medical students as well as clinicians to add some values on their level of awareness regarding to communicable diseases.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Cdc ppt for bsc nursing unit 1 11
1. CDC FOR BSC NURSING
BY GUGS A NEMERA
1BY GN 2013
2. Learning objective
At the end of the session students will be able to:
• clearly differentiate between CD and NCD
• Define at least five terms those commonly used in CD
and relate it to practical situations
• Discuss CD
2BY GN 2013
3. UNIT ONE
INTRODUCTION
Disease can be communicable or non
communicable
Communicable disease in turn classified into
several divisions based on
causative organisms
clinical presentation or system of body affected
This classification is valuable for
Clinician
Microbiologists
Epidemiologists
Parasitologsts .
3BY GN 2013
4. INTRODUCTION CONT’D
Communicable continues to remain a leading
cause of morbidity, disability and mortality
worldwide.
It accounts for one tenth of deaths in rich
countries and six out of ten deaths in poorer
countries .
for instance annually worldwide
2 m deaths occurs from diarrhea
4 m die of LRTI
700,000 die from measles
2 m die from TB
90% from developing countries
4BY GN 2013
5. Definition of common terms
(important terms)
Carrier- A person that carries a specific infectious
agent and can transmit to others but has no clinical
sign of infection.
Case - A person identified as having specific health
problem or disease of interest
Case definition- standard criteria for deciding whether
a person has particular disease or health problem.
5BY GN 2013
6. Chain of disease transmission: is a logical sequence
of factors or links of a chains that are essential for
development of the infectious agent and progression
of disease
Chemoprophylaxis- Administration of drug to
prevent the development or progression of an
infection to actual disease
Mass chemoprophylaxis
Selective chemoprophylaxis 6
Definition of common terms cont’d
BY GN 2013
7. Chemotherapy: Use of chemicals to treat a
clinically manifest disease
Assignment
Write at least 250 chemotherapeutic agent those
commonly used in Ethiopia
S.No Drug Dose Route Frequency Duration Indication
1
2
250
Definition of common terms cont’d
7BY GN 2013
8. Communicable period: the time during which an
infectious agent may be transferred directly or
indirectly from infected person to susceptible host
Contact - A person or animal that has had an
opportunity to acquire the infection following
association with infected person, animal or
contaminated environment
8
Definition of common terms cont’d
BY GN 2013
9. Control /Containment – Operation aimed at
reducing the prevalence of the disease to a level
where it is not a major public health important.
Disinfection: the killing of infectious agents
outside the body by direct exposure to physical
or chemical agents.
Sterilization – distraction of all forms of life by
heat, irradiation, gas or chemical treatment.
Definition of common terms cont’d
9BY GN 2013
10. Contamination :The presence of an infectious agent
on the body surface or other inanimate articles or
substances
Note: contamination on body surface does not
imply carrier state
Drug resistance – The ability of infectious agent to
survive despite the administration of antimicrobial in a
dose equal to or higher than the usual recommended
dose 10
Definition of common terms cont’d
BY GN 2013
11. Disinfection- the killing of infectious agents outside the body
by direct exposure to physical or chemical agents.
Concurrent disinfection→ application of disinfective
measure as soon as possible of the discharge of infectious
material from the body of an infected person or after the
soiling of material with such infectious discharge.
Terminal disinfection → is the application of disinfective
measures after the pt. has been removed by death or to
hospital, isolation or other partice has been discontinued
11
Definition of common terms cont’d
BY GN 2013
12. Sterilization – distraction of all forms of life by heat,
irradiation, gas or chemical treatment.
Disinfestations – The procedure of destroying or
removing undesired small forms of animals
particularly arthropods, rodents, present up on the
person, clothing or in the environments of an
individual or domestic animal using chemicals or
physical agents.
12
Definition of common terms cont’d
BY GN 2013
13. Elimination – eradication of disease from large
geographical region or political jurisdiction.
Endemic – Continuous presence (usual prevalence)
of a disease or infectious agent with in a
geographical area.
Epidemic or outbreak- occurrence of cases of an
illness with the frequency that is clearly in excess of
what is expected in a given region therefore
demanding emergency control.
Definition of common terms cont’d
13BY GN 2013
14. Epidemic Thresh hold- The minimum number of
cases indicating the beginning of an out breaks.
Eradication-Termination of all transmission of
infection through surveillance and control.
Host- A person or other living animal that
accommodates infectious agent under normal
conditions.
Definition of common terms cont’d
14BY GN 2013
15. Immune individual – A person or animal that has
specific protective antibody and/or cellular immunity
as a result of pervious exposure /infection,
immunization.
Immunity – resistance usually associated with the
presence of antibodies
Immunogenicity: -The ability of an agent to produce
specific immunity.
15
Definition of common terms cont’d
BY GN 2013
16. Exposure – meeting with an infectious agent in the way
that may cause disease.
Illness: -Individual or subjective feeling of discomfort.
Disease: -A state of physiological and psychological
dysfunction.
Incubation period – The time interval from the time of
infection to the time of appearance of clinical
manifestation
16
Definition of common terms cont’d
BY GN 2013
17. Infection – The entry and development of an infectious
agent in the body of humans or animals.
Nosocomial infection → An infection occurring in
patient in hospital and other health facility in whom the
infection was not present or incubating at time of
admission or residual of infection during previous
admission.
Community acquired infection – infection that occurs in
the community (general population.)
Definition of common terms cont’d
17BY GN 2013
18. Infectious agent – Bacteria, viruses, Fungi or parasites or
their products that can cause disease.
Infectious individual: A person or an animal from which
the infectious agent can be naturally acquired.
Infestation- The lodgement, development and
reproduction of arthropods on the surface of the body or
in the clothing. This also used for invasion of the gut by
parasitic worms.
Inoculums size – The minimum size of infectious agent
or its products that can cause disease. 18
Definition of common terms cont’d
BY GN 2013
19. Isolation – Keeping infected persons or animals in
separate place for as long as they can transmit
disease
Strict isolation
Contact isolation
Respiratory isolation
TB. Isolation.
Enteric precaution
Drainage /secretion precautions-
19
Definition of common terms cont’d
BY GN 2013
20. Primary or index case- A person who acquires a disease
through exposure and brings it in to population
Notifiable disease – disease for which regular, frequent
and timely information on individual cases is considered
necessary for prevention and control of disease.
Notification – The processes by which cases or out
breaks one brought to the knowledge of the health
authorities.
20
Definition of common terms cont’d
BY GN 2013
21. Quarantine- Restriction of the activity of well
person or animal who have exposed to a case
of communicable disease during its periods of
communicability.
Definition of common terms cont’d
21BY GN 2013
22. Mode of Transmission- any mechanism by
which infectious agent spread from source or
reservoir to a person.
Pollution – The presence of offensive, but not
necessarily infectious matter in the
environment
22
Definition of common terms cont’d
BY GN 2013
23. Reservoir- Any person, animal, arthropod, plant, soil
etc in which the infectious agent normally lives and
reproduce itself in such a manner that it can be
transmitted to a susceptible host.
Secondary case – A person infected by primary case.
Surveillance- Systematic collection, collation and
analysis of data, dissemination information for
action.
23
Definition of common terms cont’d
BY GN 2013
24. Susceptible host- person or animal not possessing sufficient
resistance against particular infectious agent to prevent
contracting infectious disease when exposed to it.
Transmission: any mechanism by which infectious agent
spread from source or reservoir to a person.
Direct transmission – immediate transfer of infectious agent to a
suitable portal of entry (direct contact, projection)
Indirect transmission- transfer of infectious agent through
intermediate means (vehicle born, contaminated materials vector
born)
24
Definition of common terms cont’d
BY GN 2013
25. Transmission cycle -is a cycle which describes
how an organism grows, multiplies and
spreads. In some cases man may be the only
host in which case the infection spreads
directly from man to man. E.g. measles. In
some cases like malaria the transmission cycle
involves man and mosquito
25
Definition of common terms cont’d
BY GN 2013
26. Absolute or complete quarantine, the
limitation of freedom of movement of those
exposed to a communicable disease for a
period of time not longer than the longest
incubation period of that disease in such
manner as to prevent effectual contact with
those not so exposed.
26
Definition of common terms cont’d
BY GN 2013
27. Modified quarantine: A selective partial
limitation of freedom of movement of
contacts commonly on the bases of known or
presumed differences in susceptibility and
related to the longer of disease transmission
27
Definition of common terms cont’d
BY GN 2013
28. Universal precaution – Simple standard procedure to be used
during care of patients at times to minimize the risk of
transmission.
Virulence – The ability of infectious agent to invade and
damage the tissue of the host and cause death.
Zoonoses – An infectious disease that is transmissible under
normal condition from animal to human.
Zonosis – An infection or infectious disease that is
transmissible under normal condition from vertebrate to
human.
Definition of common terms cont’d
28BY GN 2013
29. Sporadic - A disease that occur in a
population in occasional and irregular
intervals.
Pandemic – worldwide epidemic disease.
29
Definition of common terms cont’d
BY GN 2013
30. COMMUNICABLE DISEASE/ (infectious disease)
Definitions
A disease due to specific agent or its toxic products
that a rises through transmission of that agent or its
products from infected person, animal or reservoir to
susceptible host either directly or indirectly through an
intermediate plant or animal host, vector or
intermediate environment
30BY GN 2013
31. Specific feature of communicable disease
A case may be risk factor
Each infectious disease has its own incubation period
People may be immune
An individual may be a source without being recognized as a
case.
There is some times a need for urgency
Preventive measures (usually) have a good scientific ground
Intervention in infectious disease can have several effects
31BY GN 2013
32. Classification of communicable disease
It may be classified in several ways i.e. by
Clinical manifestation
Time course
Taxonomy of infectious agent
Mode of transmission
32BY GN 2013
33. Based on C/m or system involved
Diarrhoeal disease
Febrile illness
Respiratory tract infection
Central Nervous system infection
Cardiovascular system infection
UTI
Cutaneous
33BY GN 2013
34. Based on time course
Acute
Disease with short duration
needs urgent care
Rapidly progressive
Abrupt on set.
Chronic
Indicate duration usually
34BY GN 2013
35. Based on taxonomy of infectious agent
Metazoan
Protozoal
Bacterial
Fungal
Viral
35BY GN 2013
36. Based on mode of transmission
¨ Airborne diseases (respiratory tract as portal of entry and/or exit)
¨ Feco-oral transmitted diseases (GIT as entry and/or exit)
¨ Direct contact (Mucus membranes and/or skin as portal of entry /exit)
¨ Direct inoculation
¨ Vector bone disease
¨ Inoculation by bite of animal/ contacts with
animal products ( zoonosis ).
36BY GN 2013
37. Unit two:
Chain of disease transmission (diseases
transmission dynamics)
37BY GN 2013
38. Learning objective
At the end of the session students will be able to:
1.Describe Chain of disease transmission
2.List major effects of agent on the host
38BY GN 2013
39. Chain of disease transmission
Definitions
A logical order of events which must occur in
order for disease causing organisms to cause
infection.
Series that is essential to the development of
the infectious agents and propagation of
disease.
There are six successive events implicated in
the chain of disease transmission
39BY GN 2013
41. 1.Infectious Agent
• It can be an organism or its toxin
• Infection agents’ needs
Multiplication
Survival
Reservoirs
Persistence
Latency
Vector
Intermediate host
41BY GN 2013
42. Multiplication→ two methods
– Asexual (almost exact replicas produced →any
natural selection occur on the batches than single
individual.
– Sexual- scope of variety are there
42BY GN 2013
43. Survival
Agent survive by finding suitable hosts
Agent prolong the period of survival by different
methods
Reservoirs
Suitable place to store infectious agent
Reservoir can be humans, animals, vectors or
inanimate environment (soil, waters)
Persistence
–Development of special stages by agent to with
stand distraction in adverse environment. E.g. forming
cyst (protozoa), eggs (nematodes) spore (bacteria)
• 43BY GN 2013
44. Latency
–Developmental stage in the environment not
Infective to a new host.
–Parasite time of suitable condition
Vector
–Parasite use service of arthropods to transmit from
one host to other
– It can be part of transmission process (Mosquito)
Intermediate host
– some parasite needs intermediate host for
development before they invade the final host.E.g.
Schistosoma uses a molluscan 44BY GN 2013
45. Effect of the agent on host
If enough agents survive to infect a new
host, they will produce a reaction or
illness.
The effect of host is determined by
Virulence
Toxicity
Dose response
45BY GN 2013
46. 2.Reservoir of infection
A living or non living in which an infectious
agent normally lives, transforms and
multiplies on which it primarily for survival
and where it produce itself in such a way that
it can be transmitted to new susceptible host.
46BY GN 2013
47. Types of reservoir
A. Man as the only reservoir
Measles
Gonorrhoea
Syphilis
Small pox
Typhoid
Meningococcal meningitis
Transmission cycle man to man
47BY GN 2013
48. Types of reservoir cont’d
B. Animals as reservoir
Infectious disease where animals are primary
reservoirs includes:
Bovine Tuberculosis – Cow to man
Brucellosis – Cows, pigs and goats to man
Anthrax – Cattle, sheep, goats, horse to man
Rabies - Dogs, foxes, wild animal to man
Man is not essential part (usual reservoir) of
the life cycle
48BY GN 2013
49. Types of reservoir cont’d
C .Non living thing
Some of the organisms are basically saprophytes i.e.
living in soil adapted to live freely in nature and
biologically equipped to withstand marked
environmental changes.
Some of the non living reservoirs are soil, water, food
etc
Examples
Clostridium tetani of tetanus
Salmonella typhi of Typhoid fever
49BY GN 2013
50. 3.Portal of exit
¨ Site on reservoir through which an infectious
agent escapes from the reservoir.
¨ Examples
GIT – Typhoid fever, Ascariasis dysentery
Skin and mucus membrane-syphilis
RT – TBC
50BY GN 2013
51. 4.Made of transmission
Mechanism by which an infectious agent
transferred from reservoir or infected host to
new host.
Two main type of mode transmission
1. Direct transmission
2. Indirect transmission
51BY GN 2013
52. Direct transmission
Immediate transfer of infectious agent from
infected host or reservoir to an appropriate
portal of entry on the susceptible host.
Some of the ways of direct transmission are
Direct vertical – transpalcental syphilis, HIV
Direct contact – contact of if IA with skin, mucosa,
Conjunctiva
Direct touching, kissing, sexual intercourse
Direct projection – droplets of saliva created by
expiratory activity
52BY GN 2013
54. 5.Route of entry
Site on susceptible host through which an
infectious agent get into it
The manner of entry is one of the factors
which determine whether or not the
infectious agent establishes the infection
54BY GN 2013
55. 6.Susceptible host-
A person or animal lacking of sufficient
resistance to particular pathogenic agent to
prevent the disease if or when exposed.
In order for transmission to be completed, the
existence of susceptible host is necessary
55BY GN 2013
56. Level of susceptibility of depends on;
Nutritional status
Stress
Environment
Pre-existing medical condition
Immune status
Age
56BY GN 2013
58. Learning objective
• At the end of the session the learner will be
able to:
1.Describe major determinants of health using
epidemiological triad
2.Discuss the defense mechanism of the host
58BY GN 2013
59. 4.1: determinants of disease
The determinants of disease presented by
simply by Epidemiologic triad of host, agent
and environment
Host factors
Demographic
Biological
socioeconomic
Agent factors
Biological agents
Physical agents
Chemical agents
Nutrient agents
Mechanical agents
Social agents
Environment:
Physical environment
Biological environment
Social environment
59BY GN 2013
60. 4.2 Defence mechanism of the host
1. Non specific resistance or innate or natural
immunity.
2. Immune system defences
60BY GN 2013
61. Non specific resistance or innate or natural
immunity.
Are immunity used for either to prevent micro
organisms from entering the body or to
eliminate them rapidly
It includes
A. Physical barrier
B. Chemical (secreted) barrier
C. Inflammatory cells or action of white blood cells
D. Inflammatory response
61BY GN 2013
62. Physical barrier
External barrier (skin & epithelial tissue)
Internal barrier (mm)
Prevent the pathogen from entering to body.
Filtering and clearing the pathogen – cilia &
sneeze reflex
62BY GN 2013
63. Chemical (secreted) barrier
acid in stomach, enzymes in the tear and
saliva ,substances in sebaceous and sweat
secretion act non specifically for bacteria,
fungus
interferon for virus
63BY GN 2013
64. Inflammatory cells or action of white blood cells
Acting as phagocyte e.g. Monocyte and
macrophages.
Inflammatory response
The major function of natural immunity
elicited in response to tissue injury or invading
organism
64BY GN 2013
65. Immune system defences
The body has three means of defending itself
when the body invaded by agents.
1st
line defence
2nd
line of defence
3rd
. line of defence
65BY GN 2013
66. 1st
line defence
The phagocytic immune response involves WBC
(granulocyte and macrophage)
Move to the point of attack and engulf and destroy the
invading agent
2nd
line of defence
The humeral response sometimes called antibody
response
A class of protein which all anti body belong is called IG
Antibodies are produced by a class of lymphocyte called
B.cells
3rd
. line of defence (cellular immune response)/Cell mediated
immune response
Deals primary with intera-cellular pathogens
It also involves lymphocyte
66BY GN 2013
68. Learning objective
• After completion of this session students will
be able to
1.List common measures of infectiousness of CD
68BY GN 2013
69. 1 Infectivity
Ability of the infectious agent to invade and
multiply/produce an infection) in exposed host
It can be studied/measured using
The speed with which an infectious agent spreads with in a
population of close contacts /secondary attack rate
SAR = (# new cases in a group – initial cases)
(# of susceptible persons in group – initial cases)
Sero-surveys after epidemics to determine the proportion of
persons recently infected.
Measuring the progression of an infectious agent from
exposure to infection (infection rate)
Infection rate (IR) = total number of infected people x 100
Total no
susceptible people
Host and environmental factor as well as dose route of entry,
source of infection, strain of agent influence the infectivity of
an agent.
69BY GN 2013
70. 2.Pathogenicity
Ability of an agent to produce clinically
manifest disease in susceptible host.
Measured by the proportion of infections that
result in clinically apparent disease
Laboratory methods also help full
Pathogenicity = total number of clinical cases x 100
Total number of sub-clinical case
70BY GN 2013
71. Virulence
Ability of an agent to produce severs disease.
Measured by proportion of clinical cases
resulting in sever clinical manifestation
including squealed
Measure of virulence for human
Case fatality rate (CFR)
Hospitalization rate
Proportion of cases disabled or who have
developed Squeal
Proportion of cases that require different kinds of
treatment
71BY GN 2013
72. Virulence cont’d
Note
High infectivity different from High Pathogenicity
High Pathogenicity different from High virulence
e.g.
Rhinovirus infection: High Pathogenicity but low virulence
Measles infection :high Pathogenicity low
virulence
HIV: High Pathogenicity & high virulence
72BY GN 2013
73. Factor determine the degree of infectivity,
Pathogenicity and virulence
Strain of the agent e.g. N- Meningitides
Dose of the agent e.g. Cholera
Route of infection
Treatment especially on virulence
Season
Host factor
Age
Nutritional status
Immune response
73BY GN 2013
74. 4.Antigencity
Ability of the infectious agent to induce
immune response and thus an immune state
in the host.
5. Toxignocity
Refers the ability of agent to produce toxin or
Poison
6. Resistance
Ability of the agent to resist adverse
environmental condition during transmission
from one host to another
74BY GN 2013
75. 7. Disease Prevalence Rate
Number of current cases per population at risk
Old: Persistent active disease contracted previously
New: Onset of active disease
# of EXISTING cases of a specified disease
Point prevalence
Prevalence at a specific point in time
Period prevalence
Prevalence over a given time interval
Usage
Measure amount of illness in the community
Determine health care needs of the community
75BY GN 2013
76. 8. Disease Incidence Rate
Number of new disease cases per population at
risk
¨ High incidence implies high disease occurrence
¨ Low incidence implies low disease occurrence
¨ # Of NEW cases of a disease in a period of time
¨ Population at risk of developing the disease during
the same period of time
Measured over a given time interval
Usage
Determine probability of developing a specific disease
Used to detect etiologic factors
76BY GN 2013
77. 9: Immunogenicity
Infection’s ability to produce specific immunity in
the host e.g. measles
Measured by serologic surveys
Depends on:
Amount of antigen formed in the host
Site of multiplication
Agent’s ability to induce lifelong immunity
77BY GN 2013
79. unit five
Source of infection
Learning objectives
1.Explain the three main sources of infection
79BY GN 2013
80. Source of infection
There are three main sources of infection
1.Humans
2.Environment (inanimate, including food &
water)
3.Other animals
80BY GN 2013
81. A) Humans
People are colonized by a wide variety of microorganisms
most of which can become pathogenic given the right
conditions.
Normal body flora of the healthy individual vary from one
person to another depending on age, general health,
temperature and specific local condition such as acidity in
the stomach.
If normal conditions are altered, then the normal flora
may be destroyed and replaced by harmful organisms .
Any individual can be a source of infection although it is
traditional to call exogenous infection
81BY GN 2013
82. B) The inanimate environment
Soil, food and water can harbor organisms
which act as a source of injection under the
right conditions.
For example, soil can contain clostridium
species and if a traumatic penetrating injury
carries these organisms deep into tissue
anaerobic conditions may permit the organism
to multiply.
82BY GN 2013
83. C) Other animals
A variety of diseases can be spread from
animal to man and these are called zoonosis
Zoonosis is an infectious disease of animals
that may be transmitted to man.
Example Brucellosis, Rabies, Toxoplasmosis
83BY GN 2013
84. Unit six
Carriers and Infected individuals
Learning objective
1.Explain the four types of carries
84BY GN 2013
85. Carries
A person or animal that does not have apparent
clinical disease but is potential source of
infection to other people
85BY GN 2013
86. Type of carriers and its role
1.Incubatory carrier or precocious carrier (but not all
disease)
Transmitting disease during incubation period i.e. from the
time of 1st
shading to manifestation.
E.g. Mumps ,measles
2.Convalescent carrier
Transmit infection during recovery i.e. from time of recovery
to when agent stops shading
E.g. Typhoid fever ,Diphtheria
3. Asymptomatic carrier (Healthy)
Transmitting a disease without ever showing clinical
manifestation
High carrier rate e.g. Polio, Ameobiasis, meningo coccus
4.Chronic carrier
Transmitting disease for long period/ indefinite transmission
E.g. Viral Hepatitis (B, c) , Typhoid fever
86BY GN 2013
87. Unit seven
Course of an infectious disease over time
Learning objective
1.Discuss courses of an infectious disease over
time
87BY GN 2013
88. Prepatent period
¨ The time interval between infection and the point at which
infection 1st
detected(lab method).
¨ Between biological onset and the time of first shading of the
agent
¨ Measured by the 1st
shading of infectious agent by host.
2.Incubation period
Time interval between infection and the 1st
appearance
of clinical manifestation of disease i.e. between
biological and clinical on set.
Used in investigation of disease out break
88BY GN 2013
89. 3.Communicable period
The period during which an infected host can
transmit the infection to other
Measured by the length of time in which the
agent shades by host.
Degree of transmissibility does not remain
constant throughout the period of
communicability as the amount of the agent
that shade by infected host is variable at
different point in time.
89BY GN 2013
90. 4 Generation time
Onset of infection to maximal communicability
of the host (during or after incubation period)
It applies to both apparent and unapparent
infection
Focuses on transmission of infection as core
concept.
90BY GN 2013
91. 5.Latent period
The time interval between recovery and the
reoccurrence (as a relapse)
6.Prodormal period
From onset of symptom to appearance of
characteristic manifestation
91BY GN 2013
92. Unit eight
Spectrum of infectious disease/ gradient of infection/
Learning objective
1.Mention the possible outcome of infectious
disease
92BY GN 2013
93. Spectrum of infectious disease/ gradient of infection/
Spectrum means range of possible option for
something
Spectrum of infection implies the range in the
expression of disease be it in terms of the degree of
severity or clinical manifestation.
The Sequence of event takes place in the host
depending on the variety of host response.
The sequence of event may be
93BY GN 2013
94. Spectrum of infectious disease cont’d
Five type of reaction in spectrum of disease
1. No Reaction No infection
2. Sub clinical or unapparent infection
3. Atypical disease
4. Frank disease
5. Sever disease
94BY GN 2013
95. Unit nine
Natural history of disease
Learning objective
1.Define natural history of diseases
2.Explain the four stages of natural history of
diseases
95BY GN 2013
96. Natural history of disease
Definition
• A course of disease over time in the absence
of any intervention or unaffected by
treatment.
96BY GN 2013
97. Natural history cont’d
Characteristics
Each disease has its own natural history
Intervention or treatment modifies the course of
disease through time
Helps to understand the intervention measures that
could be under taken in order to prevent or control
diseases.
Has four stages
1. Stage of susceptibility
2. Stage of pre-symptomatic disease
3. Clinical stage
4. Stage of disability
97BY GN 2013
98. Natural history cont’d
Stage of susceptibility
Period of exposure
Disease has not yet developed but there are
factors that favour occurrence (risk factors)
98BY GN 2013
99. Natural history cont’d
Stage of pre-symptomatic disease – sub clinical
stage
Period of latency
Period biological onset
Disease process has already began but no s/s are
detectable
Initiation of disease process can be evidenced by
investigation methods (lab investigation)
99BY GN 2013
100. Natural history cont’d
Clinical stage
Sufficient and organ change occur
Sign and symptoms of disease appears
Severity of a disease is variable depending on the
interaction certain factor such as
¨ Nutritional status
¨ Immunity of individuals
¨ Virulence of the agent
¨ Presence or absence of medication
¨ Presence of underlying illness
100BY GN 2013
101. Natural history cont’d
Stage of disability or death (outcome)
¨ Disease has occurred and left over damage to
the body
¨ residual long or short duration disability
¨ chronicity
¨ death
¨ Note – Recovery can take place at any stage
101BY GN 2013
102. Unit ten
Epidemiology and general methods of
prevention and control of communicable
diseases
102BY GN 2013
103. Introduction to epidemiology of
communicable disease
Definition:
Epidemiology is the study of the frequency,
distribution and determinants of diseases and
other health related events in specified
populations
the application of this study to the promotion
of health and to the prevention and control of
health problems (Last 1983).
103BY GN 2013
104. Components of the definition
Population
The focus of epidemiology is mainly on the
population rather than individuals.
Frequency
Shows epidemiology to be mainly a quantitative
science
It is measured by morbidity rates which quantify the
occurrence of illness
Mortality rates which quantity the occurrence of
death
104BY GN 2013
105. Health related conditions
conditions with directly or indirectly affect or
influence health
Distribution
Refers to the geographical distribution of
diseases, the distribution in time, or / and
distribution by type of persons affected.
The part of epidemiology concerned with the
frequency and distribution of diseases by time,
person and place is named descriptive
epidemiology.
It asks the questions: - How many? Where?
When? What?
105BY GN 2013
106. Determinants
Are factors which determine whether or not a
person will get a disease, or in other words,
the causative factors for disease
The part of epidemiology dealing with the
causes and determinants of diseases is
analytical epidemiology
It asks the questions. How? Why?
106BY GN 2013
107. Importance of Studying Communicable Diseases
Epidemiology
Offers insights in to why disease and injury afflict some
people more than others
why they occur more frequently in some locations and
times than in others
applied science with direct and practical applications
For most effective ways to prevent and treat health
problems.
Discovery of new infections
The possibility that some chronic diseases have an
infective origin.
107BY GN 2013
108. General methods of prevention
and
control of communicable diseases
108BY GN 2013
109. Disease prevention
Inhibiting the development of a disease
before it occurs or if it occurs interrupting or
slowing down the progression of diseases.
109BY GN 2013
110. Disease control
Involves all the measures designed to reduce
or prevent the incidence, prevalence and
consequence of a disease to a level where it
cannot be a major public health problem.
110BY GN 2013
111. Levels of disease prevention
The different points in the progression of a
disease at which one can intervene to prevent
further out come.
There are three levels of prevention.
¨ Primary
¨ Secondary
¨ Tertiary
111BY GN 2013
112. Primary prevention
Preventing health people before becoming sick
by altering susceptibility or reducing exposure for
susceptible individuals
In order to carry out effective p° prevention
know first who is most “at risk” of getting
disease.
Purpose (Objective)
Promotion of health
Reducing incidence of disease
Prevention of exposure
Prevention of disease
112BY GN 2013
113. Health promotion
Consists of general non specific Interventions
those enhance health.
Aim at individual, communities, organizations
and Policies
Promotion measures include
¨ Improve socio economic status of the population
¨ Good nutrition, clothing, shelters, rest
¨ A void risk behaviour
¨ Broad area of health education
113BY GN 2013
114. Prevention of exposure
Any intervention which prevents the coming
in contact between an infectious agent and a
susceptible host.
This includes actions such as
Provision of safe and adequate water
proper excreta disposal
vector control
safe environment at home, at school and at work
on the streets
114BY GN 2013
115. Prevention of disease
During the latency period between exposure
and the biological onset of the disease.
An example for this is immunization.
N.B. Immunization against an infectious
organism does not prevent it from invading
the immunized host but prevents it from
establishing an infection.
115BY GN 2013
116. Prevention of disease cont’d
Breast feeding is an example of intervention that
acts at all three levels of primary Prevention.
Health promotion: By providing optimal nutrition for a
young child, either as the sole diet up to six months of
age, or as a supplement in later age.
Prevention of exposure: by reducing exposure of the
child to contaminated water.
Prevention of disease after exposure: by the provision
of ant-infective factors, including antibodies, WBCs
and others
116BY GN 2013
117. Primary prevention cont’d
Target- total population
Specific protective measures
Immunization
Environmental sanitation
Prevention against accidents
Prevention of occupational hazards
117BY GN 2013
118. Secondary prevention
(2°preventions)
Prevention after biological onset but before permanent
damage occur
Include early dictation and prompt treatment of disease in
such a way that it is possible to:
¨ Cure disease (curative medicine)
¨ Slow the progression
¨ Prevent complication
¨ Limit disability
¨ Reverse communicability
¨ Reduce prevalence.
On community-Secondary prevention for the infected
individual and p° for potential contacts
Target population→ patients (clinical or sub clinical)
118BY GN 2013
119. Tertiary prevention
Takes place after permanent damage
Important aspect of therapeutic and
rehabilitation medicine
Aim at treatment to prevent disability and
death
¨ New training and especial education to help the
patient to return to some useful work & life in
community.
Target- patient: E.g. Physiotherapy
119BY GN 2013
120. Principles of communicable disease control
Elimination of Reservoir
Immunization
Environmental control
Vector control
Surveillance
120BY GN 2013
121. Elimination of Reservoir
Man as reservoir
Detection and adequate treatment
Isolation
Quarantine
Animal as reservoir
¨ Action will be determined by usefulness of the
animal
121BY GN 2013
122. Immunization or vaccinations
BY GN 2013 122
Introductions
The new born may carries antibodies transmitted
from its mother across the placenta and from
early breast feeding which protecting at very
vulnerable stage in life
The effect of this antibody wears off after six
weeks to six month thereby the child makes their
own from natural or artificial infections
(immunizations)
123. Immunization cont’d: Definitions of
important terms
BY GN 2013 123
Vaccination: Administrations of any vaccine
or toxoids
Immunization:
The process of inducing immunity artificially
by administering antigenic substance
There are two types of immunizations;
active immunization and passive
immunization
124. Immunization cont’d: Definitions of
important terms
BY GN 2013 124
Active immunization: Involves the stimulation of
immune system to produce antibodies and
cellular immune responses that protect against
infections. Example use of vaccine agents
Passive immunization: the process of producing
temporary protection through administration of
exogenously produced anti body such as
Immunoglobulin. Example breast milk
125. Immunization cont’d: Definitions of
important terms
BY GN 2013 125
Toxoids: Modified bacterial toxin that has been made
non toxic but retain the capacity to simulate antitoxins
Immunoglobulin: an antibody containing solutions
made available for passive immunizations
Antitoxin: an antibody derived from the serum of
animals from stimulations with specific antigens which
used to provide passive immunity
126. Immunization cont’d: Definitions of
important terms
BY GN 2013 126
Vaccine: a suspension of attenuated life or killed
micro-organisms or antigenic portions of these
agents presented to potential hosts to induce
immunity and prevent disease. Vaccine can be life
attenuated, killed organisms and toxoids
Life attenuated; giving actual infection which is the
best of all; examples measles, polio, BCG
Killed organisms: used when live attenuated strain is
impossible to produce; it should be repeated.
example pertussis
127. EPI target disease in Ethiopia
BY GN 2013 127
Before 2007
øTuberculosis
øTetanus
øPertussis
øDiphtheria
øMeasles
øPoliomyelitis
After 2007
«Tuberculosis
«Tetanus
«Pertussis
«Diphtheria
«Measles
«Poliomyelitis
«Hepatitis B
«Haemophilus influenzae B
« Pneumonia
«Rota virus
128. Antigen for immunization
BY GN 2013 128
1. BCG
2. Penta-valent (DPT plus HiB&Hb)
3. Polio
4. Measles
5. Tetanus toxoids( TT)
6. PCV
7. Rota virus
129. Epidemiological case definitions of vaccine
preventable disease
BY GN 2013 129
Measles: any child with fever, red eyes, and generalized
rash within three or more days and history of cough,
runny nose.
Pertusis: any child with history persistent cough for two
or more weeks, fits, and cough followed by vomiting
Neonatal tetanus: Neonate with history of normal suck
and cry in 1st
two days of life and onset of illness between
3-28 days of age with inability to suck breast followed by
stuffiness and/or convulsions more often death
Poliomyelitis: any child less than 15 years and who have
AFP or any child who clinical suspect polio
130. EPI delivery strategy
BY GN 2013 130
Static: immunization performed as a part of
routine activities of the health institution
Outreach: is an immunization approach in which
the staff of the health unit goes out and
administers vaccine for mother and children
Mobile: a team of health unit staff go out of the
health institutions and provide immunization as
Mopping up or house to house mainly for single
dose antigens
campaign: like as national immunization days
131. Environmental control
¨ Personal and domestic hygiene
¨ Proper preparation, handling ,cooking and
storage of food
¨ Use of safe water source
¨ Proper disposal of wastes and excreta
138BY GN 2013
132. Vector control
¨ Adulticids
¨ Repellents or detergents
¨ Personal protection
¨ Larvicide’s
¨ Biological control
¨ Environmental modification
¨ Insecticides
139BY GN 2013
133. Adulticids
Killing of adult mosquito can be done while:
¨ Flying – using knock down spray
¨ Resting- Residual insecticides
Repellents or detergents
Applied on the body in the form of lotion or
smocks
Do not kill but deter from biting
Made from phyethroids but other insecticide can
be added
140BY GN 2013
134. Personal protection
Reduce the no of mosquito bite
They are cloths that cover the arms and legs
Can be combined with repellents
Mosquito nets
Larvicide’s
Act on mosquito larva by acting on
Breathing apparatus
Not effective
141BY GN 2013
135. Biological control
Use of natural methods to bring about
reduction in vector
Environmental modification
Making the environment no longer suitable
for existence of the vector
E.g. draining of water
142BY GN 2013
136. Insecticides
Poisons – Paris green
Fumigants
Hydrogen cyanides, methyl bromide and ethylformate
used on body or clothing to destroy infestation
Knock down – Pyrethrum
Residual insecticide
Organo chlorines
dichlorodiphenyltrichloroethane (DDT)
Benzenehexahloride (RHC) - Dieldrin
kill or reduce time of contact
Organophosphate e.g. Malathion
inhibits cholinesterase at nerve junction and cause paralysis
143BY GN 2013
138. Surveillance
Surveillance is a continuous collection, analysis,
interpretation and dissemination of health information
for the purpose of monitoring health events, and using
the information for prevention and control of health
problems.
Key qualities (elements) of surveillance
Its continuous activity
Its ability to detect changes in ecology or incidence of
disease.
The dissemination of pertinent information for action.
Although surveillance is applicable to all types of
diseases, primary attention should be directed towards
disease amenable to effective control
145BY GN 2013
140. Active surveillance
A collection of data usually on specific disease or
health related events for relatively limited period
of time by regular outreach on the part of health
department personnel.
A system in health staff make periodic field visits
to health care facilities to identify new cases or
death from disease (case finding)
Involves
Interviewing clinicians and pts
Reviewing health records
Surveying villages in under developed countries
147BY GN 2013
141. Characteristics of Active surveillance
¨ Identify Local outbreak
¨ More expensive to maintain and establish as it
require good organization, funds and
resources.
¨ More accurate and complete than passive
148BY GN 2013
142. Passive surveillance
• Surveillance in which either available data on
reportable disease are used or reporting is
mandated or requested with the responsibility
often failing on health care provider or district
health officer.
149BY GN 2013
143. Characteristics of Passive surveillance
¨ Problems with under reporting or lack of
completeness
¨ May dilute small out breaks in the total
regional pupation
¨ In expensive and easily implemented
¨ Allow for international comparison
¨ Data is analyzed centrally
¨ Wide coverage requiring without specific
arrangement
150BY GN 2013
144. Types of passive surveillance
Total passive
carried out through predetermined reports
submitted at regular intervals
Simulated passive surveillance
¨ surveillance team request reports from third
parties
151BY GN 2013
145. Step to be followed in surveillance
1.Collection of data
Name, age, sex address, occupation, vaccination,
Treatment, place of infection, source of infection,
exposed susceptible e
1.Compilation and analysis of data
analysis can be made of cases by person, place and
time.
1.Formulation of recommendation for action
2.dissemination and feed back
higher authorities
Person and institution involved in notification &
control program
To the community.
152BY GN 2013
146. Out break
Occurrences of more cases of disease than
expected in a given area among specific group
of people over particular period of time.
153BY GN 2013
147. Outbreak is:
A public, political and economic emergency
An unusual event
An event requiring rapid action
A failure of surveillance
An opportunity /for training, Research…)
154BY GN 2013
148. Reason to investigate out break
Control /prevention
Research opportunity
Training
Public political and legal concern
155BY GN 2013
149. Steps in outbreak investigation
1.Preparation for field work
A. Investigation
Have appropriate scientific knowledge, supplies
and equipment to carry out investigation
Discuss with someone who is knowledgably about
the disease.
Review applicable literature.
B. Administration
C. Consultation
156BY GN 2013
150. 2. Establish the existence of our break
3. Varity the diagnosis
4. Establish case definition
Include clinical criteria and restriction by time
place and person.
must be applied to all without bias
Type
Possible – Fewer of typical clinical features
Probable – Typical clinical feature without lab
investigation.
Confirmed
157BY GN 2013
151. 5. Perform descriptive epidemiology.
Time- when do they become ill?
Place- where do they live
Person- who are the cases
5Develop hypothesis
source of the agent, made of transmission etc
Who is becoming ill?
What is a disease
What is the source and the vehicle
What is the mode of transmission
158BY GN 2013
152. 6. Test hypothesis
Compare with established facts When clinical,
lab environmental and/or epidemiological
data undoubtedly support hypothesis
8. Refine hypothesis and do additional studies
159BY GN 2013
153. 9. Implement control measures
Control source of pathogen
Interrupt transmission (vector contrle
,personal & environmental sanitation)
Modify host response :
Vaccination
Prophylaxis
Treatment
10. Communicate the findings
160BY GN 2013
154. Learning objective
1.List at least four diseases under national
regulation
2. list diseases under international regulation
161
Unit twelve
Notification and health regulation
BY GN 2013
155. Introduction to Notification and health regulation
International health regulations Require that
certain disease are notified
Purpose
To warn other countries and intended travellers to
the country of health risk involved For assistance
Disease under international health regulation
¨ Plaque, cholera, yellow fever, Ebola
162BY GN 2013
156. Disease under surveillance by WHO
Louse borne typhus fever
RF
Paralytic poliomyelitis
Malaria
Influenza
AIDS
Small pox
Diphtheria, typhoid whooping cough
163BY GN 2013
158. Integrated disease surveillance and response
Functional disease surveillance system is
useful for priority setting, planning
mobilization and allocation of resources,
production and early detection of epidemics,
monitoring and evaluation of intervention
programs.
165BY GN 2013
160. 2. Disease selected for case based surveillance
Measles
Poliomyelitis
Dracunculiasis (Guinea worm)
Neonatal tetanus
3 .Other diseases of public health importance
Diarrhoea in <5 years of age
Pneumonia
AIDS
Onchocerciasis
STI
TB
167BY GN 2013